(USAC) USA Compression Partners - Overview
Sector: EnergyIndustry: Oil & Gas Equipment & Services | Exchange NYSE (USA) | Currency USD | Market Cap: 4.155m | Total Return 15.4% in 12m
Stock: Gas Compression, Treating, Cooling, Dehydration
Total Rating 51
Risk 75
Buy Signal 0.06
| Risk 5d forecast | |
|---|---|
| Volatility | 27.0% |
| Relative Tail Risk | -3.92% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.49 |
| Alpha | 2.38 |
| Character TTM | |
|---|---|
| Beta | 0.576 |
| Beta Downside | 0.671 |
| Drawdowns 3y | |
|---|---|
| Max DD | 24.35% |
| CAGR/Max DD | 0.87 |
EPS (Earnings per Share)
Revenue
Description: USAC USA Compression Partners March 04, 2026
USA Compression Partners, LP (USAC) provides natural gas compression services across the United States. Its services support various energy sector participants, including oil and gas producers, processors, and transporters. The natural gas compression sector is critical for maintaining pressure in pipelines and optimizing gas flow.
USAC also offers natural gas treating services, such as the removal of impurities and dehydration. These services are essential for preparing natural gas for pipeline transmission and commercial use, ensuring it meets quality specifications.
As of December 31, 2025, USACs fleet comprised 3.9 million horsepower. This reflects the significant capital investment typical in the energy infrastructure sector. To understand the implications of this scale, further research on ValueRay is recommended.
Headlines to watch out for
- Natural gas demand impacts compression service utilization
- Oil and gas drilling activity drives new contract awards
- Commodity prices influence customer capital expenditure
- Interest rates affect debt servicing costs
Piotroski VR‑10 (Strict, 0-10) 5.0
| Net Income: 111.3m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.11 > 0.02 and ΔFCF/TA 5.60 > 1.0 |
| NWC/Revenue: 4.98% < 20% (prev 4.66%; Δ 0.31% < -1%) |
| CFO/TA 0.15 > 3% & CFO 394.3m > Net Income 111.3m |
| Net Debt (2.54b) to EBITDA (606.6m): 4.19 < 3 |
| Current Ratio: 1.27 > 1.5 & < 3 |
| Outstanding Shares: last quarter (124.2m) vs 12m ago 5.15% < -2% |
| Gross Margin: 59.81% > 18% (prev 0.68%; Δ 5.91k% > 0.5%) |
| Asset Turnover: 37.20% > 50% (prev 34.62%; Δ 2.59% > 0%) |
| Interest Coverage Ratio: 1.72 > 6 (EBITDA TTM 606.6m / Interest Expense TTM 187.4m) |
Altman Z''
| A: 0.02 (Total Current Assets 236.6m - Total Current Liabilities 186.9m) / Total Assets 2.62b |
| B: error (Retained Earnings missing) |
| C: 0.12 (EBIT TTM 321.8m / Avg Total Assets 2.68b) |
| D: -0.04 (Book Value of Equity -112.5m / Total Liabilities 2.73b) |
Beneish M -3.10
| DSRI: 0.88 (Receivables 82.5m/89.1m, Revenue 998.1m/950.4m) |
| GMI: 1.13 (GM 59.81% / 67.52%) |
| AQI: 0.97 (AQ_t 0.08 / AQ_t-1 0.08) |
| SGI: 1.05 (Revenue 998.1m / 950.4m) |
| TATA: -0.11 (NI 111.3m - CFO 394.3m) / TA 2.62b) |
| Beneish M-Score: -3.10 (Cap -4..+1) = AA |
What is the price of USAC shares?
As of March 27, 2026, the stock is trading at USD 28.46 with a total of 299,860 shares traded.
Over the past week, the price has changed by -0.25%, over one month by +3.12%, over three months by +26.93% and over the past year by +15.39%.
Over the past week, the price has changed by -0.25%, over one month by +3.12%, over three months by +26.93% and over the past year by +15.39%.
Is USAC a buy, sell or hold?
USA Compression Partners has received a consensus analysts rating of 3.00.
Therefor, it is recommend to hold USAC.
- StrongBuy: 0
- Buy: 1
- Hold: 4
- Sell: 1
- StrongSell: 0
What are the forecasts/targets for the USAC price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 28.2 | -1% |
| Analysts Target Price | 28.2 | -1% |
USAC Fundamental Data Overview March 23, 2026
P/E Trailing = 33.7176
P/E Forward = 19.7628
P/S = 4.1628
P/B = 24.8274
P/EG = -68.32
Revenue TTM = 998.1m USD
EBIT TTM = 321.8m USD
EBITDA TTM = 606.6m USD
Long Term Debt = 2.52b USD (from longTermDebt, last quarter)
Short Term Debt = 4.82m USD (from shortTermDebt, last quarter)
Debt = 2.55b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 2.54b USD (from netDebt column, last quarter)
Enterprise Value = 6.70b USD (4.15b + Debt 2.55b - CCE 8.56m)
Interest Coverage Ratio = 1.72 (Ebit TTM 321.8m / Interest Expense TTM 187.4m)
EV/FCF = 24.18x (Enterprise Value 6.70b / FCF TTM 277.0m)
FCF Yield = 4.14% (FCF TTM 277.0m / Enterprise Value 6.70b)
FCF Margin = 27.75% (FCF TTM 277.0m / Revenue TTM 998.1m)
Net Margin = 11.15% (Net Income TTM 111.3m / Revenue TTM 998.1m)
Gross Margin = 59.81% ((Revenue TTM 998.1m - Cost of Revenue TTM 401.2m) / Revenue TTM)
Gross Margin QoQ = 38.18% (prev 69.25%)
Tobins Q-Ratio = 2.56 (Enterprise Value 6.70b / Total Assets 2.62b)
Interest Expense / Debt = 1.78% (Interest Expense 45.3m / Debt 2.55b)
Taxrate = 1.89% (536k / 28.3m)
NOPAT = 315.7m (EBIT 321.8m * (1 - 1.89%))
Current Ratio = 1.27 (Total Current Assets 236.6m / Total Current Liabilities 186.9m)
Debt / Equity = -22.67 (negative equity) (Debt 2.55b / totalStockholderEquity, last quarter -112.5m)
Debt / EBITDA = 4.19 (Net Debt 2.54b / EBITDA 606.6m)
Debt / FCF = 9.18 (Net Debt 2.54b / FCF TTM 277.0m)
Total Stockholder Equity = -62.3m (last 4 quarters mean from totalStockholderEquity)
RoA = 4.15% (Net Income 111.3m / Total Assets 2.62b)
RoE = -178.7% (negative equity) (Net Income TTM 111.3m / Total Stockholder Equity -62.3m)
RoCE = 13.07% (EBIT 321.8m / Capital Employed (Equity -62.3m + L.T.Debt 2.52b))
RoIC = 12.83% (NOPAT 315.7m / Invested Capital 2.46b)
WACC = 5.63% (E(4.15b)/V(6.71b) * Re(8.01%) + D(2.55b)/V(6.71b) * Rd(1.78%) * (1-Tc(0.02)))
Discount Rate = 8.01% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 9.83%
[DCF] Terminal Value 80.82% ; FCFF base≈220.8m ; Y1≈145.0m ; Y5≈66.3m
[DCF] Fair Price = N/A (negative equity: EV 2.10b - Net Debt 2.54b = -438.2m; debt exceeds intrinsic value)
EPS Correlation: 95.70 | EPS CAGR: 144.1% | SUE: -0.59 | # QB: 0
Revenue Correlation: 95.92 | Revenue CAGR: 12.30% | SUE: -0.62 | # QB: 0
EPS next Quarter (2026-06-30): EPS=0.33 | Chg7d=+0.036 | Chg30d=+0.036 | Revisions Net=+1 | Analysts=2
EPS current Year (2026-12-31): EPS=1.41 | Chg7d=-0.029 | Chg30d=-0.029 | Revisions Net=+1 | Growth EPS=+38.7% | Growth Revenue=+30.9%
EPS next Year (2027-12-31): EPS=1.78 | Chg7d=+0.069 | Chg30d=+0.069 | Revisions Net=+1 | Growth EPS=+26.1% | Growth Revenue=+5.2%
[Analyst] Revisions Ratio: +1.00 (1 Up / 0 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 5.0% (Discount Rate 8.0% - Earnings Yield 3.0%)
[Growth] Growth Spread = +25.3% (Analyst 30.3% - Implied 5.0%)
P/E Forward = 19.7628
P/S = 4.1628
P/B = 24.8274
P/EG = -68.32
Revenue TTM = 998.1m USD
EBIT TTM = 321.8m USD
EBITDA TTM = 606.6m USD
Long Term Debt = 2.52b USD (from longTermDebt, last quarter)
Short Term Debt = 4.82m USD (from shortTermDebt, last quarter)
Debt = 2.55b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 2.54b USD (from netDebt column, last quarter)
Enterprise Value = 6.70b USD (4.15b + Debt 2.55b - CCE 8.56m)
Interest Coverage Ratio = 1.72 (Ebit TTM 321.8m / Interest Expense TTM 187.4m)
EV/FCF = 24.18x (Enterprise Value 6.70b / FCF TTM 277.0m)
FCF Yield = 4.14% (FCF TTM 277.0m / Enterprise Value 6.70b)
FCF Margin = 27.75% (FCF TTM 277.0m / Revenue TTM 998.1m)
Net Margin = 11.15% (Net Income TTM 111.3m / Revenue TTM 998.1m)
Gross Margin = 59.81% ((Revenue TTM 998.1m - Cost of Revenue TTM 401.2m) / Revenue TTM)
Gross Margin QoQ = 38.18% (prev 69.25%)
Tobins Q-Ratio = 2.56 (Enterprise Value 6.70b / Total Assets 2.62b)
Interest Expense / Debt = 1.78% (Interest Expense 45.3m / Debt 2.55b)
Taxrate = 1.89% (536k / 28.3m)
NOPAT = 315.7m (EBIT 321.8m * (1 - 1.89%))
Current Ratio = 1.27 (Total Current Assets 236.6m / Total Current Liabilities 186.9m)
Debt / Equity = -22.67 (negative equity) (Debt 2.55b / totalStockholderEquity, last quarter -112.5m)
Debt / EBITDA = 4.19 (Net Debt 2.54b / EBITDA 606.6m)
Debt / FCF = 9.18 (Net Debt 2.54b / FCF TTM 277.0m)
Total Stockholder Equity = -62.3m (last 4 quarters mean from totalStockholderEquity)
RoA = 4.15% (Net Income 111.3m / Total Assets 2.62b)
RoE = -178.7% (negative equity) (Net Income TTM 111.3m / Total Stockholder Equity -62.3m)
RoCE = 13.07% (EBIT 321.8m / Capital Employed (Equity -62.3m + L.T.Debt 2.52b))
RoIC = 12.83% (NOPAT 315.7m / Invested Capital 2.46b)
WACC = 5.63% (E(4.15b)/V(6.71b) * Re(8.01%) + D(2.55b)/V(6.71b) * Rd(1.78%) * (1-Tc(0.02)))
Discount Rate = 8.01% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 9.83%
[DCF] Terminal Value 80.82% ; FCFF base≈220.8m ; Y1≈145.0m ; Y5≈66.3m
[DCF] Fair Price = N/A (negative equity: EV 2.10b - Net Debt 2.54b = -438.2m; debt exceeds intrinsic value)
EPS Correlation: 95.70 | EPS CAGR: 144.1% | SUE: -0.59 | # QB: 0
Revenue Correlation: 95.92 | Revenue CAGR: 12.30% | SUE: -0.62 | # QB: 0
EPS next Quarter (2026-06-30): EPS=0.33 | Chg7d=+0.036 | Chg30d=+0.036 | Revisions Net=+1 | Analysts=2
EPS current Year (2026-12-31): EPS=1.41 | Chg7d=-0.029 | Chg30d=-0.029 | Revisions Net=+1 | Growth EPS=+38.7% | Growth Revenue=+30.9%
EPS next Year (2027-12-31): EPS=1.78 | Chg7d=+0.069 | Chg30d=+0.069 | Revisions Net=+1 | Growth EPS=+26.1% | Growth Revenue=+5.2%
[Analyst] Revisions Ratio: +1.00 (1 Up / 0 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 5.0% (Discount Rate 8.0% - Earnings Yield 3.0%)
[Growth] Growth Spread = +25.3% (Analyst 30.3% - Implied 5.0%)